Liquid Biopsy clinical trials at UCSF
1 research study open to eligible people
Liquid biopsy is a method to detect cancer cells in the blood. UCSF is conducting a study to safely disrupt the blood-brain barrier to gather samples from brain tumors. This trial involves patients with glioblastoma brain tumors.
Showing trials for
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects with GlioBlastoma Brain Tumors
open to eligible people ages 18-80
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects with suspected Glioblastoma brain tumors
San Francisco, California and other locations
Last updated: